Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) Gross Margin (2016 - 2018)

ENDRA Life Sciences (NDRA) has disclosed Gross Margin for 3 consecutive years, with 100.0% as the latest value for Q1 2018.

  • Quarterly Gross Margin changed N/A to 100.0% in Q1 2018 from the year-ago period, while the trailing twelve-month figure was 100.0% through Dec 2018, up 4914.0% year-over-year, with the annual reading at 100.0% for FY2018, 4914.0% up from the prior year.
  • Gross Margin for Q1 2018 was 100.0% at ENDRA Life Sciences, up from 54.96% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q1 2018, with the low at 10.98% in Q2 2017.
  • Average Gross Margin over 3 years is 55.8%, with a median of 54.96% recorded in 2017.
  • Peak annual rise in Gross Margin hit 71bps in 2017, while the deepest fall reached 71bps in 2017.
  • Over 3 years, Gross Margin stood at 54.25% in 2016, then rose by 1bps to 54.96% in 2017, then skyrocketed by 82bps to 100.0% in 2018.
  • According to Business Quant data, Gross Margin over the past three periods came in at 100.0%, 54.96%, and 58.79% for Q1 2018, Q4 2017, and Q3 2017 respectively.